Cleared Traditional

K152115 - Renew NCP-5 External Counterpulsation System (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K152115 · Stage 2 Innovations · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2015
Decision
141d
Days
Class 2
Risk

K152115 is an FDA 510(k) clearance for the Renew NCP-5 External Counterpulsation System. Classified as Device, Counter-pulsating, External (product code DRN), Class II - Special Controls.

Submitted by Stage 2 Innovations (Rockville, US). The FDA issued a Cleared decision on December 17, 2015 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5225 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Stage 2 Innovations devices

Submission Details

510(k) Number K152115 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2015
Decision Date December 17, 2015
Days to Decision 141 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 125d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRN Device, Counter-pulsating, External
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRN Device, Counter-pulsating, External

All 33
Devices cleared under the same product code (DRN) and FDA review panel - the closest regulatory comparables to K152115.
Pression Wave PRO External Counter-Pulsation System
K250756 · Pression, Inc. · Dec 2025
External Counterpulsation System, Soulaire
K202108 · Vamed Medical Instrument Co., Ltd. · Aug 2020
Enhanced External Counter Pulsation Device Plus Omay-A
K191955 · Omay(Guangzhou)Med Technologies Co., Ltd. · Aug 2020
External Counterpulsation System
K190683 · Vamed Medical Instrument Co., Ltd. · Sep 2019